Dergiler / The Anatolian Journal of Cardiology / 2018 / Cilt: 19 - Sayı: 1

Association of Interleukin-1 Gene cluster polymorphisms with coronary slow flow phenomenon

Sayfa
34–41
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

It may suggest that the tendency for inflammationmay contribute to the presence of this phenomenon.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Coronary slow flow phenomenon (CSFP) is characterized by the decreased rate of contrast progression in epicardial coronary arteriesin the absence of significant coronary stenosis.
📊
Temel Bulgular & Veri:Mounting evidence has showed a significant association between inflammation and CSFPseverity.
💡
Sonuç & Katkı:It may suggest that the tendency for inflammationmay contribute to the presence of this phenomenon.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Coronary slow flow phenomenon (CSFP) is characterized by the decreased rate of contrast progression in epicardial coronary arteriesin the absence of significant coronary stenosis. Mounting evidence has showed a significant association between inflammation and CSFPseverity. This study aimed to evaluate possible associations between interleukin-1 receptor antagonist (IL-1ra) gene variable number tandemrepeat (VNTR), IL-1β -511 single nucleotide (SNP), and IL-1β+3954 SNP mutations with CSFP.Methods: Forty-eight patients with CSFP and 62 controls with angiographically normal coronary arteries were prospectively enrolled in the study.Genotypes were assessed using the polymerase chain reaction (PCR)-based restriction fragment length polymorphism (PCR-RFLP) technique.Results: Homozygote genotype for allele 2 of+3954 C>T 2/2 genotype was significantly more frequent in patients with CSFP than in the controlgroup, whereas 1/2 genotype was more frequent in the control group (35.4% versus 14.5% for 2/2 genotype and 25% versus 35.5% for 1/2 genotypein CSFP and control groups, respectively, X2=6.6; p=0.04). The allelic frequency of allele 2 of this polymorphism was significantly higher inthe CSFP group than in the control group (47.9% versus 28.6% in the control group, X2=5.6; p=0.02). However, there was no significant differencewith regard to genotype or allelic frequencies of IL-1ra VNTR or IL-1β -511 SNP polymorphisms between patients with CSFP and controls.Conclusion: IL-1β+3954 SNP mutations are significantly more common in patients with CSFP. It may suggest that the tendency for inflammationmay contribute to the presence of this phenomenon.

🔖

Bu Makaleye Atıf Yap

MUTLUER, F. O., URAL, D., GÜNGÖR, B., BOLCA, O., AKSU, T. (2018). Association of Interleukin-1 Gene cluster polymorphisms with coronary slow flow phenomenon. The Anatolian Journal of Cardiology, Cilt: 19 - Sayı: 1, 34–41. https://ajindex.com/articles/365294

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. Durda P, Sabourin J, Lange EM, Nalls MA, Mychaleckyj JC, Jenny NS, et al. Plasma Levels of Soluble Interleukin-2 Receptor alpha: Associations With Clinical Cardiovascular Events and Genome-Wide Association Scan. Arterioscler Thromb Vasc Biol 2015; 35: 2246-53.
  2. Coker A, Arman A, Soylu O, Tezel T, Yıldırım A. Lack of association between IL-1 and IL-6 gene polymorphisms and myocardial infarction in Turkish population. Int J Immunogenet 2011; 38: 201-8. [CrossRef] Soylu O, Yıldırım A, Coker A, Tezel T, List EO, Arman A. Interleukin-1B (-511) gene polymorphism is associated with acute coronary syndrome in the Turkish population. Eur Cytokine Netw 2008; 19: 42-8.
  3. Zhou L, Cai J, Liu G, Wei Y, Tang H. Associations between interleukin-1 gene polymorphisms and coronary heart disease risk: a metaanalysis. PLoS One 2012; 7: e45641. [CrossRef] Durakoğlugil ME, Kocaman SA, Çetin M, Kırbaş A, Canga A, Erdoğan T, et al. Increased circulating soluble CD40 levels in patients with slow coronary flow phenomenon: an observational study. Anadolu Kardiyol Derg 2013; 13: 39-44.
  4. Li JJ, Qin XW, Li ZC, Zeng HS, Gao Z, Xu B, et al. Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow. Clin Chim Acta 2007; 385: 43-7. [CrossRef] Yurtdaş M, Yaylalı YT, Kaya Y, Özdemir M. Increased plasma highsensitivity C-reactive protein and myeloperoxidase levels may predict ischemia during myocardial perfusion imaging in slow coronary flow. Arch Med Res 2014; 45: 63-9. [CrossRef] Altaş Y, Kurtoğlu E, Yaylak B, Baysal E, Ucaman B, Uğurlu HM, et al. The relationship between eosinophilia and slow coronary flow. Ther Clin Risk Manag 2015; 11: 1187-91. [CrossRef] Doğan M, Akyel A, Çimen T, Bilgin M, Sunman H, Kasapkara HA, et al. Relationship between neutrophil to lymphocyte ratio and slow coronary flow. Clin Appl Thromb Hemost 2015; 21: 251-4. [CrossRef] Özyurtlu F, Yavuz V, Çetin N, Acet H, Ayhan E, Işık T. The association between coronary slow flow and platelet distribution width among patients with stable angina pectoris. Postepy Kardiol Interwencyjnej 2014; 10: 161-5. [CrossRef] Pekdemir H, Çicek D, Çamsarı A, Akkuş MN, Cin VG, Doven O, et al. The relationship between plasma endothelin-1, nitric oxide levels, and heart rate variability in patients with coronary slow flow. Ann Noninvasive Electrocardiol 2004; 9: 24-33. [CrossRef] Madak N, Nazlı Y, Mergen H, Aysel S, Kandaz M, Yanık E, et al. Acute phase reactants in patients with coronary slow flow p